Frost edit · Free shipping over $70 · Cool essentials
Login Register
evernorth glp-1

evernorth glp-1 cigna expands program to help employers curb costs Cigna dropping GLP-1 obesity drug – GLP-1s are accelerating spending growth

SKU: 71379140016
4.4
USD23.58 USD43.58

Pay in 4 interest-free payments of $5.89 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 2 - Sep 7

Description

Kidouchi, N

evernorth glp-1 cigna expands program to help employers curb costs Cigna dropping GLP-1 obesity drug GLP-1s are accelerating spending growth

The SURMOUNT-5 trial directly compared the two medications and found tirzepatide produced approximately 20 percent weight loss compared to 14 percent for semaglutide

evernorth glp-1 cigna expands program to help employers curb costs Cigna dropping GLP-1 obesity drug GLP-1s are accelerating spending growth

The doses, licensed uses, and weight loss results differ

evernorth glp-1 cigna expands program to help employers curb costs Cigna dropping GLP-1 obesity drug GLP-1s are accelerating spending growth

These are the three main active ingredients that are used in medications approved for weight loss, diabetes management, and other health purposes

evernorth glp-1 cigna expands program to help employers curb costs Cigna dropping GLP-1 obesity drug GLP-1s are accelerating spending growth
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products